Adults 18 to 110, any sex, with Hospice. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Participant Recruitment RatePrimary· During recruitment (22 months)
Recruitment rate was measured by the number of participants consented divided by the number of eligible participants.
Group
Value
95% CI
All Participants
37.7
Participant Attrition From Enrollment to End of StudyPrimary· At the end of the intervention or at 6 weeks, which ever is earlier.
This measure is the total number of participants who withdrew consent or were unreachable for study activities after consent.
Group
Value
95% CI
Control Arm
0
I-HoME Intervention
5
Average Length of I-HoME Tele-visitPrimary· At the end of the intervention or at 6 weeks, which ever is earlier.
This measure was collected by calculating the average duration (in minutes) of each tele-visit between the participant in I-HoME intervention arm and the interventionalist.
Group
Value
95% CI
I-HoME Intervention
22.5
± 11.32
Total Number of Educational Videos Watched by I-HoME Intervention Arm ParticipantsPrimary· At the end of the intervention or at 6 weeks, which ever is earlier.
This measure is the total number of videos watched by the I-HoME intervention arm participants who received at least one tele-visit. Intervention arm participants self-reported whether they watched the educational videos recommended to them by the interventionist.
Group
Value
95% CI
I-HoME Intervention
23
Number of I-HoME Intervention Caregivers Who Experienced Technical Issues During the Tele-visits.Primary· At the end of the intervention or at 6 weeks, which ever is earlier.
The number of I-HoME intervention caregivers who reported at least one technical issues with the tele-visit. Participants in the intervention arm answered questions about whether they experienced technical issues.
Group
Value
95% CI
Control Arm
0
I-HoME Intervention
13
Control Arm
0
I-HoME Intervention
22
Percentage of Tele-visits Conducted Out of the Total Possible Tele-visits.Primary· At the end of the intervention or at 6 weeks, which ever is earlier.
This measure is calculated by dividing the tele-visits conducted out of the total possible tele-visits. This measure shows the adherence of the I-HoME intervention arm to the tele-visits.
Group
Value
95% CI
I-HoME Intervention
89.6
Patients' Symptom Burden Score as Rated by the Caregiver, Measured at Baseline and Weekly for 6 Weeks.Secondary· At baseline and weekly for 6 weeks.
Symptom burden score as measured by the Edmonton Symptom Assessment Scale (ESAS). Scale is from a 0 to 90, with higher scores indicating higher symptom burden.
Baseline ESAS Score
Group
Value
95% CI
Control Arm
39.0
± 13.9
I-HoME Intervention
43.7
± 17.6
Week 1 ESAS Score
Group
Value
95% CI
Control Arm
38.0
± 16.7
I-HoME Intervention
40.7
± 19.6
Week 2 ESAS Score
Group
Value
95% CI
Control Arm
34.6
± 15.1
I-HoME Intervention
42.5
± 16.8
Week 3 ESAS Score
Group
Value
95% CI
Control Arm
34.7
± 15.9
I-HoME Intervention
42.3
± 16.1
Week 4 ESAS Score
Group
Value
95% CI
Control Arm
34.9
± 16.5
I-HoME Intervention
38.8
± 19.2
Week 5 ESAS Score
Group
Value
95% CI
Control Arm
37.0
± 16.1
I-HoME Intervention
44.1
± 17.9
Week 6 ESAS Score
Group
Value
95% CI
Control Arm
36.1
± 15.6
I-HoME Intervention
39.9
± 20.1
Sponsor's own description
With the growth of hospice, older adults have the opportunity to receive home-based care aimed at reducing suffering and focusing on quality of life at the end of life. While use of technology and educational videos has yet to be fully developed, structured, and evaluated in home hospice care, it has shown promise to improve care in other settings. Therefore, this study aims to develop and evaluate a multi-component technology-based care intervention, i.e., Improving Home hospice Management of End of life issues through technology (I-HoME).
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
NCT06488157 — Adapting and Implementing the I-HoME Intervention in Caregivers of Patients With ADRD
· NA
· completed
NCT04074304 — Developing and Piloting a Multi-component Technology-based Care Intervention to Address Patient Symptoms and Caregiver B
· NA
· completed
Other recruiting trials for Hospice
Currently open trials in the same condition.
NCT07512505 — Remote Vital Sign Monitoring in Palliative Care Patients Using a Wearable ECG Monitor
· recruiting
NCT06835764 — A Telenovela Intervention for Caregivers of African-American and Hispanic Hospice Patients
· NA
· active not recruiting
Other Weill Medical College of Cornell University trials
Trials by the same sponsor.
NCT07485712 — Center for Research and Education on Aging and Technology Enhancement - CREATE V - Project 2
· NA
· not yet recruiting
NCT05811338 — Center for Research and Education on Aging and Technology Enhancement - CREATE V - Project 1
· NA
· not yet recruiting
NCT06118983 — Improving TRansitions ANd OutcomeS for Heart FailurE Patients in Home Health CaRe (I-TRANSFER-HF)
· NA
· recruiting
NCT06818734 — Implementation of a Clinical Decision Support Tool for Postpartum Depression
· NA
· not yet recruiting
NCT07485725 — Center for Research and Education on Aging and Technology Enhancement - CREATE V - Project 3
· NA
· not yet recruiting
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Weill Medical College of Cornell University
Last refreshed: 7 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04243538.